Latest Breaking News On - Indianapolis based lilly - Page 1 : vimarsana.com

Lilly to invest additional $5.3B in Lebanon research and innovation district

Lilly to Invest Additional $5.3 Billion in Lebanon Research and Innovation District

Patients on hunt for diabetes, obesity and weight-loss drugs – Indianapolis Business Journal

Lilly’s newest obesity and diabetes medicines, widely known as GLP-1 drugs, are drawing rave reviews from doctors, researchers and patients for their ability to safely and effectively control blood sugar and take off weight.

Eli Lilly buying Nexus Pharmaceuticals facility

Riley Children's Foundation lands $8M gift from Lechleiters - The Daily Reporter

Lilly partners with Amazon for free medicine delivery, 24/7 pharmacy access

Indianapolis-based Lilly has partnered with Amazon Pharmacy to offer free medication delivery and access to clinical pharmacists.

In race to develop obesity drugs, Roche acquires California biotech for $2.7B – Inside INdiana Business

In race to develop obesity drugs, Roche acquires California biotech for $2.7B – Indianapolis Business Journal

The company, Carmot Therapeutics, has numerous drugs under development. Its lead asset is a once-a-week injection that is in mid-stage development for the treatment of obesity.

FDA authorizes use of diabetes drug tirzepatide for weight loss

The Food and Drug Administration has authorized Zepbound, which is manufactured by Eli Lilly, approval to be prescribed as a weight-management treatment, paving the way for more people to gain access to the medication.

Point Biopharma insiders to reap millions from Lilly deal – Inside INdiana Business